1. Home
  2. BHR vs UNCY Comparison

BHR vs UNCY Comparison

Compare BHR & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BHR

Braemar Hotels & Resorts Inc.

HOLD

Current Price

$2.38

Market Cap

159.3M

Sector

Real Estate

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$7.26

Market Cap

145.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHR
UNCY
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.3M
145.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BHR
UNCY
Price
$2.38
$7.26
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$25.67
AVG Volume (30 Days)
340.4K
554.8K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
8.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$675,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$582.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.85
$0.47
52 Week High
$3.19
$7.78

Technical Indicators

Market Signals
Indicator
BHR
UNCY
Relative Strength Index (RSI) 42.49 55.46
Support Level $2.34 $5.95
Resistance Level $2.62 $7.32
Average True Range (ATR) 0.10 0.39
MACD 0.00 0.07
Stochastic Oscillator 27.14 65.13

Price Performance

Historical Comparison
BHR
UNCY

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury hotels and resorts. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: